|15.56||0||0.00||Vol 352.27K||1Y Perf 28.07%|
|Jul 30th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||16.42||Analyst Rating||Strong Buy 1.14|
|Potential %||5.53||Finscreener Ranking||★★+ 48.08|
|Insiders Trans % 3/6/12 mo.||-/100/100||Value Ranking||★+ 42.98|
|Insiders Value % 3/6/12 mo.||-/100/100||Growth Ranking||★ 35.77|
|Insiders Shares Cnt. % 3/6/12 mo.||-/100/100||Income Ranking||★★★★ 51.38|
|Market Cap||945.95M||Earnings Rating||Buy|
|Price Range Ratio 52W %||90.85||Earnings Date||3rd Aug 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||3rd Aug 2021|
|Estimated EPS Next Report||0.22|
|EPS Growth Next 5 Years %||8.00|
|Avg. Weekly Volume||185.38K|
|Avg. Monthly Volume||276.61K|
|Avg. Quarterly Volume||500.57K|
Global Medical REIT Inc. (NYSE: GMRE) stock closed at 15.56 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 352.20K shares and market capitalization of 945.95M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the REITs industry, Real Estate sector and employs 4 people. Global Medical REIT Inc. CEO is Jeffrey Busch.
The one-year performance of Global Medical REIT Inc. stock is 28.07%, while year-to-date (YTD) performance is 19.14%. GMRE stock has a five-year performance of 42.49%. Its 52-week range is between 11.39 and 15.98, which gives GMRE stock a 52-week price range ratio of 90.85%
Global Medical REIT Inc. currently has a PE ratio of -94.20, a price-to-book (PB) ratio of 1.87, a price-to-sale (PS) ratio of 12.26, a price to cashflow ratio of 20.10, a PEG ratio of 2.32, a ROA of -0.67%, a ROC of 1.35% and a ROE of -1.67%. The company’s profit margin is -5.24%, its EBITDA margin is 57.40%, and its revenue ttm is $77.38 Million , which makes it $1.27 revenue per share.
Of the last four earnings reports from Global Medical REIT Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.22 for the next earnings report. Global Medical REIT Inc.’s next earnings report date is 03rd Aug 2021.
The consensus rating of Wall Street analysts for Global Medical REIT Inc. is Strong Buy (1.14), with a target price of $16.42, which is +5.53% compared to the current price. The earnings rating for Global Medical REIT Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Global Medical REIT Inc. has a dividend yield of 5.25% with a dividend per share of $0.82 and a payout ratio of 1 000.00%.
Global Medical REIT Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.20, ATR14 : 0.29, CCI20 : 110.02, Chaikin Money Flow : 0.21, MACD : 0.16, Money Flow Index : 65.21, ROC : 2.71, RSI : 57.21, STOCH (14,3) : 80.00, STOCH RSI : 0.33, UO : 53.33, Williams %R : -20.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Global Medical REIT Inc. in the last 12-months were: Jeffrey Busch (Buy at a value of $158 068), Ronald Marston (Buy at a value of $53 200)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.